XT
PBM icon

XTX Topco’s Psyence Biomedical PBM Stock Holding History

XTX Topco’s Portfolio PBM Stock Details PBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.2K Buy
+15,094
New +$68.6K ﹤0.01% 3735

Other funds holding PBM

PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.93B AUM 16.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CJ
Caitlin John Brighton, Michigan $183M AUM 30.77% 1-Year Est. Return

XTX Topco's PBM Position: Q2 2026 in Review

XTX Topco opened a new position in Psyence Biomedical (PBM) in Q2 2026: 15,094 shares worth $46.2K. The stake represents ﹤0.01% of the portfolio and ranks #3735 among its holdings.

9 funds tracked by Wall St. Rank hold PBM as of Q2 2026.

  • XTX Topco held 15,094 shares of Psyence Biomedical worth $46.2K as of Q2 2026.
  • Psyence Biomedical was a new XTX Topco position in Q2 2026.
  • Psyence Biomedical made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3735 holding.
  • 9 funds tracked by Wall St. Rank held Psyence Biomedical as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.